Total planned funding: $132,616,136
Allocations
Countries/Regions
India | $132,616,136 |
Organizational Types
NGO | $45,459,099 |
Unknown | $40,669,399 |
Own Agency | $23,849,754 |
University | $15,182,112 |
Private Contractor | $2,589,272 |
Multi-lateral Agency | $2,200,000 |
FBO | $1,100,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $48,038,427 |
Prevention | $34,179,944 |
Care | $19,495,829 |
Management and Operations | $16,818,487 |
Testing | $7,242,605 |
Treatment | $6,840,844 |
Budget Codes
OHSS: Health Systems Strengthening | $27,543,556 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,208,088 |
HVMS: Management and Operations | $16,818,487 |
HVSI: Strategic Information | $16,680,809 |
HBHC: Care: Adult Care and Support | $12,437,695 |
HVCT: Testing: HIV Testing and Counseling | $7,242,605 |
HTXS: Treatment: Adult Treatment | $6,505,573 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,478,266 |
HKID: Care: Orphans and Vulnerable Children | $4,275,409 |
HLAB: Laboratory Infrastructure | $3,814,062 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,355,455 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,613,868 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,301,418 |
PDCS: Care: Pediatric Care and Support | $481,307 |
PDTX: Treatment: Pediatric Treatment | $311,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$40,044,910
Countries/Regions
FHI 360:
$13,841,011
Countries/Regions
USG Aggregated Agencies:
$10,707,272
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions